Last reviewed · How we verify

NCT06306352

Vibrotactile Feedback in Exoskeletons

Completed NA Last updated 12 March 2024
What this trial tests

NA trial testing Vibrotactile feedback in Spinal Cord Injuries in 7 participants. Completed in 21 June 2023.

Timeline
6 March 2023
Primary endpoint
21 June 2023
21 June 2023

Quick facts

Lead sponsorSint Maartenskliniek
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment7
Start date6 March 2023
Primary completion21 June 2023
Estimated completion21 June 2023
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Sint Maartenskliniek — full company profile →

Who can join

18 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the impact of providing discrete vibrotactile feedback related to weight shift and step initiation on exoskeleton use in individuals with motor-complete SCI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other Sint Maartenskliniek trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06306352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing